Specialty Pharma Journal Specialty, Precision & Technology
LUGANO, Switzerland and SAN DIEGO, Aug. 8, 2016 PRNewswire — Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced that they have entered into an exclusive …
Tag Archives: MEI Pharma
August, 2016
-
1 August
MEI Pharma’s Pracinostat Receives Breakthrough Therapy Designation from the FDA
SAN DIEGO, Aug. 1, 2016 /PRNewswire/ — MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational drug Pracinostat in combination with azacitidine for …
March, 2015
-
23 March
MEI Pharma’s Lead Cancer Drug Fails in Phase II Study
MEI Pharma’s lead cancer drug failed to meet the primary goal in a mid-stage study, causing shares to drop to a 52-week low. The company announced top-line data from a Phase II clinical trial evaluating its investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 …